Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05JEG
|
||||
Former ID |
DIB008154
|
||||
Drug Name |
BMN-701
|
||||
Synonyms |
IGF2-GAA; XC-701; ZC-701; Enzyme replacement therapy (GILT, Pompe disease), BioMarin/ZyStor
|
||||
Indication | Pompe's disease [ICD10:E74.02] | Phase 3 | [524401] | ||
Company |
Biomarin pharmaceutical
|
||||
Target and Pathway | |||||
Target(s) | Lysosomal alpha-glucosidase | Target Info | Modulator | [524362], [551880] | |
Pathway Interaction Database | Notch-mediated HES/HEY network | ||||
PathWhiz Pathway | Galactose Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.